DE | EN
|
A A+
Search
BlueSky
Youtube
Instagram
Facebook
Linkedin
Urologie
UrologyUniversity departmentsMedical University of Graz

Research

Research at the Department of Urology covers a wide variety of subspecialties. In recent years, one clear focus has been on uro-oncological research, not least because of rapid advances worldwide in drug therapy for tumors that have metastasized. This applies to cancerous tumors of the prostate, kidney, bladder, penis and testicles.

Forschung

Focus on the patient

As part of our research activities, we can also enable our patients to participate in international studies with promising and innovative therapeutic approaches.

Research focus

Forschung

We have established various areas of focus in order to further our research activities. These core topics are currently being researched intensively at our clinic by internationally renowned research groups.

Current research projects

MoonRISe-1

MoonRISe-1 (Recruitment closed)

The MoonRISe-1 trial targets patients with intermediate-risk non-muscle-invasive bladder cancer (IR-NMIBC) who are FGFR-positive. In this trial, an intravesical TAR device is being prospectively and randomly tested against the standard of care (MMC).

We were able to enroll a total of 11 patients (2 in the TAR group, 9 in the MMC group), making us the leading center in Austria.

Contact
Projekt Vektor

VEKTOR

VEKTOR is a prospective, randomized, single-center non-inferiority study that directly compares the surgical procedures TUR-P, HoLEP, and Rezūm™ for the treatment of BPS. The aim is to compare the efficacy, safety, and impact on quality of life, sexual function, and reoperation rates of these three procedures. The target population consists of all patients with BPS who are candidates for surgery and have a prostate volume of 30–80 ml.

Contact
Urothelkarzinom

Urothelial Carcinoma Patient Journey (PJBCa; Recruitment ongoing)

PJBCa is used to systematically track the course of the disease in patients with urothelial carcinoma in order to improve diagnosis and treatment decisions.

Contact
Strike

StrikeBC

StrikeBC ist eine österreichweite Kollaborationsinitiative im Rahmen der LBG-Klinischen Forschungsgruppen mit dem Ziel, die Versorgung und Forschung bei fortgeschrittenem Blasenkrebs durch innovative klinische Studien, translationale Forschung, moderne Datenintegration und eine strukturierte Forschungsplattform nachhaltig zu verbessern. Das Netzwerk vereint Expert*innen verschiedener Fachrichtungen aus Universitätskliniken und Forschungsinstituten in ganz Österreich, um neue Diagnose-, Biomarker- und Therapiestrategien sowie patientenzentrierte Entscheidungsmodelle zu entwickeln und zu evaluieren. Ein besonderer Schwerpunkt liegt auf der aktiven Einbindung von Patient*innenvertretungen sowie auf der Förderung effizienter, datengetriebener Forschung und der Ausbildung der nächsten Generation von Forscher*innen.

Weitere Informationen hierzu finden Sie unter

Conference contributions – Committed to science and continuing education

ÖBAY 2025 – 51st Conference of the Austrian Society of Urology and the Bavarian Urologists Association

  • Poster: The correlation of metabolic metabolites with image morphological, genetic, and biological markers in suspected prostate cancer, Johannes Mischinger
  • Poster: Clinically significant tumor histology in primary elective transurethral resection of the bladder, Conrad Leitsmann
  • Poster: Performance Comparison of the Histolog® Scanner and Frozen Section Analysis During Robot-Assisted Radical Prostatectomy, Lukas Scheipner

Research initiatives

Zum Wohle der Patient*innen.
Access for employees

Our research achievements

Projects

Research projects conducted at our department
Projekte

Publications

Scientific publications from our department
Publikationen